N-Acetylgalactosaminidase Alpha (NAGA) Antibody Pair

1573€ (5 × 96 tests)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
N-Acetylgalactosaminidase Alpha (NAGA) Antibody Pair
category
Antibody Pairs
provider
Abbexa
reference
abx370394
tested applications
ELISA
Description
N-Acetylgalactosaminidase Alpha (NAGa) Antibody Pair for use in Sandwich ELISA assay development.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Antibody Pairs |
Immunogen Target | N-Acetylgalactosaminidase Alpha (NAGA) |
Reactivity | Mouse |
Assay Data | Detection Antibody Biotinilated |
Assay Type | Sandwich |
Recommended Dilution | Dilute the Capture Antibody 125-fold with Coating Buffer. Dilute the Biotin-Conjugated Detection Antibody 200-fold with Detection Antibody Diluent. Optimal dilutions/concentrations should be determined by the end user. |
Size 1 | 5 × 96 tests |
Size 2 | 10 × 96 tests |
Form | Standard: Lyophilized--Liquid (Capture Antibody and Detection Antibody) Reconstitute the standard with Standard Diluent. The volume, and therefore standard concentration, should be determined by the end user. |
Tested Applications | ELISA |
Buffer | The Capture and Detection Antibody both contain 0.1% sodium azide. |
Availability | Please enquire. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Alias | GALB, D22S674 |
Background | Antibody Pair for NAGA |
Status | RUO |
Note | This antibody pair contains ( 5 x 96 det): Detection: 50 µg Capture: 200 µg Standard: 2 µg This product is for research use only. |
Descripción
N-Acetylgalactosaminidase Alpha (NAGA) is an enzyme involved in the breakdown of complex carbohydrates. catalyzes the hydrolysis of terminal alpha-N-acetylgalactosaminyl residues in glycoproteins and glycolipids (lysosomes), Deficiency in NAGA enzyme activity leads to a rare genetic disorder known as Schindler disease, which is characterized by the accumulation of certain glycoproteins and glycolipids in lysosomes. Schindler disease can manifest in different forms, including Schindler disease type I and type II, depending on the severity of the enzyme deficiency. Symptoms of Schindler disease can vary widely but may include developmental delay, intellectual disability, seizures, skeletal abnormalities, and other neurological and systemic manifestations. The severity and progression of the disease can also vary, ranging from mild to severe.
Related Products

Human NAGA (Alpha-N-acetylgalactosaminidase) ELISA Kit
Ver Producto
Rat Naga (Alpha-N-acetylgalactosaminidase) ELISA Kit
Ver Producto
NAGA antibody
NAGA belongs to the glycosyl hydrolase 27 family. It removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. It is required for the breakdown of glycolipids. Biosynthetic studies performed with cultured fibroblasts indicated that the human enzyme was synthesized as a 65kDa glycosylated precursor which was processed to a mature 48-kDa lysosomal form; both the precursor and mature forms had high mannose type oligosaccharide chains, but only the precursor’s mannose residues were phosphorylated. 90-117kd is a homodimer of NAGA.
Ver Producto